Angeles Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Angeles Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-938	Closed	-$618K	–	156
2021 Q4	$618K	Buy	938 +407	+77%	+$255K	0.03%	104
2021 Q3	$330K	Hold	531	–	–	0.02%	153
2021 Q2	$335K	Sell	531 -43	-7%	-$23.7K	0.02%	103
2021 Q1	$281K	Hold	574	–	–	0.02%	93
2020 Q4	$287K	Hold	574	–	–	0.03%	92
2020 Q3	$226K	Buy	+574	New	+$212K	0.03%	95
2020 Q2	–	Sell	-993	Closed	-$271K	–	108
2020 Q1	$271K	Sell	993 -78	-7%	-$20.4K	0.07%	75
2019 Q4	$280K	Sell	1,071 -45	-4%	-$11.9K	0.06%	69
2019 Q3	$303K	Buy	+1,116	New	+$311K	0.07%	55

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Angeles Investment Advisors's IDXX Position: Q1 2022 in Review

Angeles Investment Advisors sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 938 shares — an estimated $618K sold.

Angeles Investment Advisors first reported a position in IDXX in Q3 2019 and held it in 9 quarters. The position peaked at $618K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Angeles Investment Advisors reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Angeles Investment Advisors sold 938 Idexx Laboratories shares in Q1 2022, an estimated $618K.
Angeles Investment Advisors first reported a position in Idexx Laboratories in Q3 2019 and held it in 9 quarters.
Angeles Investment Advisors's Idexx Laboratories position peaked at $618K in Q4 2021.
1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Angeles Investment Advisors's 13F filing for Q1 2022, filed 16 May 2022.